CoChat

Radiosensitizing effects of silver nanoparticles targeting angiogenesis and matrix metalloproteinase signaling in triple negative breast cancer cell lines

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

Triple-negative breast cancer (TNBC) is a highly aggressive subtype with few treatment options and limited response to radiation therapy due to radioresistance. This study explores the anti-angiogenic and anti-migratory potential of silver nanoparticles (Ag-NPs) as radiosensitizers in TNBC cell lines (MDA-MB-231 and MDA-MB-468). Cells were exposed to Ag-NPs and RT. Cell viability was assessed by MTT and trypan blue exclusion assay. Apoptosis and intracellular reactive oxygen species (ROS) were detected by flow cytometry. Angiogenesis-related genes were evaluated by qPCR, while MMP2 and MMP9 protein levels were determined by western blotting. Cell migration and tube formation were assessed using a scratch assay and an endothelial tube formation assay, respectively. Combination of Ag-NPs with RT exhibited strong synergistic anticancer effects in TNBC cell lines. The combinational treatment significantly enhanced apoptosis and ROS production compared to control and individual treatments. It also reduced VEGFR2 and Tie2 gene expression in both cell lines and decreased MMP2 and MMP9 protein levels in MDA-MB-231 cells. Cell migration and tube formation were significantly impaired in MDA-MB-231 cells exposed to combination therapy. Ag-NPs enhanced the cytotoxic effects of RT in TNBC cell lines by increasing apoptosis and ROS, and suppressing cell migration and angiogenic activity, suggesting their potential as a radiosensitizer to improve therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-026-35662-8

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The viability of MDA-MB-231, MDA-MB-468, and MCF-10A cells treated with Ag-NPs and RT. (a) Dose response curve of MDA-MB-2325, MDA-MB-468 and MCF-10A were treated with Ag-NPs for 48 h. Dose–response curves were obtained by GraphPad Prism Software. The Fa-CI plot was generated by Compusyn software to evaluate combination effects. The anticancer effects of each monotherapy and combination therapy were assessed using the Trypan Blue Exclusion assay. Data are reported as the mean ± SD (standard deviation) from three independent biological and technical replicates (n = 3). CI: Combination index. Fa: Fraction of cells affected by the combination therapy. *** p < 0.001.
Fig. 1 The viability of MDA-MB-231, MDA-MB-468, and MCF-10A cells treated with Ag-NPs and RT. (a) Dose response curve of MDA-MB-2325, MDA-MB-468 and MCF-10A were treated with Ag-NPs for 48 h. Dose–response curves were obtained by GraphPad Prism Software. The Fa-CI plot was generated by Compusyn software to evaluate combination effects. The anticancer effects of each monotherapy and combination therapy were assessed using the Trypan Blue Exclusion assay. Data are reported as the mean ± SD (standard deviation) from three independent biological and technical replicates (n = 3). CI: Combination index. Fa: Fraction of cells affected by the combination therapy. *** p < 0.001.CC BY-NC-ND · PubMed Central
Fig. 2 Flow cytometric analysis of apoptosis in MDA-MB-231 and MDA-MB-468 cells following monotherapies and combination treatment. Representative dot plot and corresponding barograph of apoptosis in (a) MDA-MB-231cells treated with Ag-NPs (4 µg/ml), RT (4 Gray), and their combination, and (b) in MDA-MB-468 cells treated with Ag-NPs (7 µg/ml), RT (8 Gray), and their combination. Quantification of apoptotic cells was performed using GraphPad Prism software. Data represent mean ± SD from three independent experiments (n = 3). ### p < 0.001 compared to CTRL (untreated group). *** p < 0.001 vs. each treatment group.
Fig. 2 Flow cytometric analysis of apoptosis in MDA-MB-231 and MDA-MB-468 cells following monotherapies and combination treatment. Representative dot plot and corresponding barograph of apoptosis in (a) MDA-MB-231cells treated with Ag-NPs (4 µg/ml), RT (4 Gray), and their combination, and (b) in MDA-MB-468 cells treated with Ag-NPs (7 µg/ml), RT (8 Gray), and their combination. Quantification of apoptotic cells was performed using GraphPad Prism software. Data represent mean ± SD from three independent experiments (n = 3). ### p < 0.001 compared to CTRL (untreated group). *** p < 0.001 vs. each treatment group.CC BY-NC-ND · PubMed Central
Fig. 3 Detection of intracellular ROS in MDA-MB-231 cells and MDA-MB-468 following monotherapy and combination treatment (a). Representative histogram and quantitative bar graph show ROS production. (a) MDA-MB-231cells treated with Ag-NPs (4 µg/ml), RT (4 Gray), and their combination, and (b) in MDA-MB-468 cells treated with Ag-NPs (7 µg/mL), RT (8 Gray), and their combination. Intracellular ROS levels were detected by flow cytometry using a commercial ROS detection Kit. Each data point represents the mean ± SD from three independent experiments (n = 3). ## p < 0.01 and ### p < 0.001 vs. control group. ** p < 0.01 and *** p < 0.001 vs. each treatment group. ns: not significant.
Fig. 3 Detection of intracellular ROS in MDA-MB-231 cells and MDA-MB-468 following monotherapy and combination treatment (a). Representative histogram and quantitative bar graph show ROS production. (a) MDA-MB-231cells treated with Ag-NPs (4 µg/ml), RT (4 Gray), and their combination, and (b) in MDA-MB-468 cells treated with Ag-NPs (7 µg/mL), RT (8 Gray), and their combination. Intracellular ROS levels were detected by flow cytometry using a commercial ROS detection Kit. Each data point represents the mean ± SD from three independent experiments (n = 3). ## p < 0.01 and ### p < 0.001 vs. control group. ** p < 0.01 and *** p < 0.001 vs. each treatment group. ns: not significant.CC BY-NC-ND · PubMed Central
Fig. 4 Evaluation of VEGFR2 and Tie2 mRNA expression in MDA-MB-231 and MDA-MB-468 cells following monotherapy and combination treatment. Relative mRNA expression of VEGFR2 and Tie2 was determined by real-time PCR in (a) MDA-MB-231 and (b) MDA-MB-468 cells. The cells were exposed to Ag-NPs, RT, and their combination for 48 h. Β-actin was used as an internal control. Data are represented as the mean ± SD from three independent experiments (n = 3). ns; non-significant. #p < 0.01, and ###p < 0.001 vs. untreated group *p < 0.05, **p < 0.01, and ***p < 0.001 vs. each treated group.
Fig. 4 Evaluation of VEGFR2 and Tie2 mRNA expression in MDA-MB-231 and MDA-MB-468 cells following monotherapy and combination treatment. Relative mRNA expression of VEGFR2 and Tie2 was determined by real-time PCR in (a) MDA-MB-231 and (b) MDA-MB-468 cells. The cells were exposed to Ag-NPs, RT, and their combination for 48 h. Β-actin was used as an internal control. Data are represented as the mean ± SD from three independent experiments (n = 3). ns; non-significant. #p < 0.01, and ###p < 0.001 vs. untreated group *p < 0.05, **p < 0.01, and ***p < 0.001 vs. each treated group.CC BY-NC-ND · PubMed Central
Fig. 5 Western blot analysis of MMP2 and MMP9 protein expression in MDA-MB-231 cells following Ag-NPs (4 µg/ml), RT (4 Gray), or combination therapy (4 µg/ml + 4 Gray). (a) Representative image of western blot analysis and (b, c, and d) relative quantification of MMP2/9 protein expression normalized to β-actin (Supplementary File; Sect. 1). All values were presented as the mean ± SD from three independent experiments (n = 3). Ns: non-significant. #p < 0.05, and ###p < 0.001 vs. untreated group *p < 0.05, **p < 0.01, and ***p < 0.001 vs. each treated group.
Fig. 5 Western blot analysis of MMP2 and MMP9 protein expression in MDA-MB-231 cells following Ag-NPs (4 µg/ml), RT (4 Gray), or combination therapy (4 µg/ml + 4 Gray). (a) Representative image of western blot analysis and (b, c, and d) relative quantification of MMP2/9 protein expression normalized to β-actin (Supplementary File; Sect. 1). All values were presented as the mean ± SD from three independent experiments (n = 3). Ns: non-significant. #p < 0.05, and ###p < 0.001 vs. untreated group *p < 0.05, **p < 0.01, and ***p < 0.001 vs. each treated group.CC BY-NC-ND · PubMed Central
Fig. 6 Bar graph depicting (a) the percentage of cell-free area over time (0 h, 24 h, 48 h) by scratch assay and (b) the number of junctions by tube formation assay in MDA-MB-231 cells. The cells were treated with Ag-NPs (4 µg/ml), radiation (4 Gray), or combination therapy (4 µg/ml + 4 Gray). Combination therapy significantly inhibited the migration and tube formation of MDA-MB-231 cells. The results are presented as fold changes in wound width relative to the control group. Data represent mean ± SD from three independent experiments (n = 3).
Fig. 6 Bar graph depicting (a) the percentage of cell-free area over time (0 h, 24 h, 48 h) by scratch assay and (b) the number of junctions by tube formation assay in MDA-MB-231 cells. The cells were treated with Ag-NPs (4 µg/ml), radiation (4 Gray), or combination therapy (4 µg/ml + 4 Gray). Combination therapy significantly inhibited the migration and tube formation of MDA-MB-231 cells. The results are presented as fold changes in wound width relative to the control group. Data represent mean ± SD from three independent experiments (n = 3).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

8 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Research works printed but not linked: 1

  1. Jyoti, K., Singh, A., Fekete, G. & Singh, T. Cytotoxic and radiosensitizing potential of silver nanoparticles against HepG-2 cells prepared by biosynthetic route using Picrasma quassioides leaf extract. J. Drug Deliv. Sci. Technol. 55, 101479 (2020).

Cited by

See all 6

Metadata

Authors
Montazersaheb, S., Farahzadi, R., Mansouri, E., Jafari, S., & Fathi, E.
Affiliations
  • Tabriz University of Medical Sciences (IR)
  • University of Tabriz (IR)
Corresponding author
  • Jafari, Sevda
  • Fathi, Ezzatollah
Venue
Scientific Reports
Published
2026-01-31
Volume
16
Issue
1
Pages
6820-6820
ISSN
2045-2322 (ISSN-L)
OpenAlex
W7126415109
Cited by
5
References
49
Citations by year
2026: 5
FWCI
23.55
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Tabriz University of Medical Sciences
  • University of Tabriz
Topics
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
  • Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
silver nanoparticles, radiosensitization, triple-negative breast cancer, radioresistance (biology), angiogenesis, MMP-2, MMP-9, VEGFR2, Tie2, reactive oxygen species, apoptosis, cell migration, tube formation, combination therapy
MeSH terms
MDA-MB-231 Cells, Angiogenesis, Cell Movement, Female, Humans, Radiation-Sensitizing Agents, Silver, Blotting, Western, Signal Transduction, Apoptosis, Reactive Oxygen Species, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, Matrix Metalloproteinases, Cell Line, Tumor, Metal Nanoparticles, Real-Time Polymerase Chain Reaction, Triple Negative Breast Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Radiosensitizing effects of silver nanoparticles targeting angiogenesis and matrix metalloproteinase signaling in triple negative breast cancer cell lines. https://app.cochat.ai/papers/10.1038/s41598-026-35662-8
The paper
Montazersaheb, S., Farahzadi, R., Mansouri, E., Jafari, S., & Fathi, E. (2026). Radiosensitizing effects of silver nanoparticles targeting angiogenesis and matrix metalloproteinase signaling in triple negative breast cancer cell lines. Scientific Reports. https://doi.org/10.1038/s41598-026-35662-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.